A novel anti-HER2 monoclonal antibody IAH0968 in HER2-positive heavily pretreated solid tumors: results from a phase Ia/Ib first-in-human, open-label, single center study

Authors

Yunpeng Liu (ORCID: https://orcid.org/0000-0003-3306-2470)
Xiujuan Qu (ORCID: https://orcid.org/0009-0005-9366-2314)
S. Jiang
Liusong Yin (ORCID: https://orcid.org/0000-0002-4425-5502)
Aodi Li (ORCID: https://orcid.org/0009-0001-0634-079X)
L. Tong (ORCID: https://orcid.org/0000-0002-7369-4811)
Lei Zhao (ORCID: https://orcid.org/0000-0002-9878-4530)
Jing Shi (ORCID: https://orcid.org/0000-0001-7156-8128)
Yuee Teng (ORCID: https://orcid.org/0000-0002-9198-9795)
Ping Yu (ORCID: https://orcid.org/0000-0001-9239-9044)
Yule Liu (ORCID: https://orcid.org/0000-0002-4423-6045)
Jin Wang (ORCID: https://orcid.org/0000-0002-7956-9579)
Zan Teng (ORCID: https://orcid.org/0000-0001-9095-696X)
Lingyun Zhang (ORCID: https://orcid.org/0000-0003-4480-4927)
Jian Cui (ORCID: https://orcid.org/0000-0002-2403-4964)
Jinglei Qu
Tie Xu
Bo Jin (ORCID: https://orcid.org/0000-0003-2000-5119)
Xiaoling Jiang (ORCID: https://orcid.org/0000-0002-6635-590X)
Na Song (ORCID: https://orcid.org/0000-0001-7793-570X)